✦ LIBER ✦

608 Pegylated interferon α-2b plus ribavirin in the re-treatment of patients non responsive to IFN/ribavirin

Book ID: 117374114
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 121 KB
Volume: 42
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)82019-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated Interferon Alfa-2b Plus Ribavi

Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients

✍ Gloria Taliani; Giulia Gemignani; Carlo Ferrari; Antonio Aceti; Dario Bartolozzi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Pegylated α interferon 2B plus ribavirin

Pegylated α interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection

✍ Tawhida Yassin Abdel Ghaffar; Suzan El Naghy; Hatem El Sebaie; Magda El Monaiery 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 122 KB

548 Efficacy of PEG-interferon α-2B (PEG

548 Efficacy of PEG-interferon α-2B (PEG-IFN) plus ribavirin in responder-relapsers to a previous course of interferon α plus ribavirin

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Pegylated interferon α-2b plus ribavirin

Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients

✍ Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenthe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Neutralizing antibodies to interferon-α

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy*)

✍ Philippe Halfon; Sophie Pérusat; Marc Bourlière; Jean-Pierre Bronowicki; Pascale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract A lack of antiviral response in patients with chronic hepatitis C treated with pegylated (PEG)‐interferon (IFN)‐α‐2a + ribavirin (RIBA) may be explained by neutralizing antibodies to IFN‐α‐2a. The aim of this study was to assess neutralizing antibodies to IFN‐α‐2a and IFN levels in non‐